Celanese (CE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
4 Mar, 2026Executive summary
Board and management focused on long-term shareholder value, financial flexibility, and strategic transformation, including divestitures and capital allocation priorities.
CEO emphasized operational excellence, cost discipline, and free cash flow as key financial objectives, with targeted portfolio actions to accelerate deleveraging.
Board refreshment continued, adding directors with diverse skills and recent C-suite experience, and maintaining a balance of tenure and expertise.
Active shareholder engagement addressed board leadership, governance, compensation alignment, and sustainability.
Voting matters and shareholder proposals
Shareholders will vote on the election of nine directors, ratification of KPMG LLP as independent auditor for 2026, and an advisory say-on-pay vote on executive compensation.
Board recommends voting FOR all director nominees, auditor ratification, and executive compensation approval.
Proxy access allows shareholders with 3% ownership for 3 years to nominate up to 2 directors or 20% of the board.
Board of directors and corporate governance
Board consists of nine nominees, eight of whom are independent; independent Chair and CEO roles are separated.
Board committees include Audit, Compensation and Management Development, Nominating and Corporate Governance, Stewardship, and Finance and Business Review.
Annual board and committee self-evaluations, majority voting standard, and no mandatory term limits.
Director compensation includes cash and equity, with robust stock ownership guidelines and annual reviews.
Latest events from Celanese
- Sales and operating profit grew, but financing costs and restructuring drove a $253 million loss.CE
Q4 2004 - Pricing and productivity lifted FY 2005 profit, but leverage and input-cost risks persisted.CE
Q4 2005 - Pricing and productivity lifted FY 2006 operating profit 30.3% to $747M.CE
Q4 2006 - Pricing and currency lifted sales 12%, while outages, costs and refinancing weighed on results.CE
Q4 2007 - Recession cut earnings, but cash improved and recovery was expected in 2010.CE
Q4 2009 - Recovery lifted sales and operating profit; 2011 growth was expected across all segments.CE
Q4 2010 - FY11 earnings grew on pricing and mix, while major capacity and ethanol investments set up the next growth phase.CE
Q4 2011 - Acetyl pricing and currency dragged FY12 results; 12%–14% earnings growth targeted for FY13.CE
Q4 2012 - A $742 million relocation gain drove record reported profit amid mixed segment trends.CE
Q4 2013 - Sales and adjusted EPS advanced as record cash flow funded growth and shareholder returns.CE
Q4 2014